112:
Belkin was part of the team investigating the implantation of pre-treated macrophages into rats stimulated tissue repair. This procedure was later extended to human trials for spinal injury patients and established that humans could tolerate the procedure. He was one of the first to use stem cells in
208:
Knoller, Nachshon; Auerbach, Gustavo; Fulga, Valentin; Zelig, Gabriel; Attias, Josef; Bakimer, Ronit; Marder, Jonathan B.; Yoles, Eti; Belkin, Michael; Schwartz, Michal; Hadani, Moshe (2005). "Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury:
94:
and in the UK at Queens
University Belfast and Moorfields Eyes Hospital, London in 2018. In 1998, he developed a novel miniature glaucoma shunt, named ex-PRESS. The implant is commonly used in glaucoma surgery. He was involved in developing and clinically proving a method to treat adult amblyopia
80:
Belkin developed the novel
External Automatic Glaucoma Laser (EAGLE), a Direct Selective Trabeculoplasty (DSLT) device to change conventional glaucoma management from a specialized procedure to a procedure which general ophthalmologists can perform. Belkin's company BELKIN Laser Ltd was part of a
68:
Belkin is a Senior
Scientific Advisor to the Singapore National Eye Centre. Belkin founded Belkin Laser Ltd. in 2013 and served as the company's Chief Medical Officer. He serves on the board and scientific advisory board of various companies engaged in developing novel ophthalmic technologies.
81:
multidisciplinary, multinational consortium that successfully received EU funding of 2480275 Euros in 2016. Under the project title GLAUrious this consortium aimed to ease commercialization of the EAGLE technology and drive adoption by general ophthalmologists.
61:
Belkin served as head of the
Research, Development and Non-Conventional Warfare Medicine department of the Israel Defence Forces Medical Corps for three years. During that time, he development military goggles to protect the eyes of soldiers.
540:
Nelson, Darin A.; Krupsky, Sara; Pollack, Ayala; Aloni, Eyal; Belkin, Michael; Vanzetta, Ivo; Rosner, Mordechai; Grinvald, Amiram (1 January 2005). "Special Report: Noninvasive Multi-Parameter
Functional Optical Imaging of the Eye".
398:
Hirschberg, David L.; Yoles, Eti; Belkin, Michael; Schwartz, Michal (1994). "Inflammation after axonal injury has conflicting consequences for recovery of function: Rescue of spared axons is impaired but regeneration is supported".
436:
Assia, Ehud; Rosner, Mordechai; Belkin, Michael; Solomon, Arie; Schwartz, Michal (1989). "Temporal parameters of low energy laser irradiation for optimal delay of post-traumatic degeneration of rat optic nerve".
267:
Battler, Alexander; Scheinowitz, Mickey; Bor, Amir; Hasdai, David; Vered, Zvi; Di Segni, Elio; Varda-Bloom, Nira; Nass, Devorah; Engelberg, Santiago; Eldar, Michael; Belkin, Michael; Savion, Naphtali (1993).
1274:
Knoller, Nachshon; Auerbach, Gustavo; Fulga, Valentin; Zelig, Gabriel; Attias, Josef; Bakimer, Ronit; Marder, Jonathan B.; Yoles, Eti; Belkin, Michael; Schwartz, Michal; Hadani, Moshe (2005).
503:
Eitan, S; Solomon, A; Lavie, V; Yoles, E; Hirschberg, D.; Belkin, M; Schwartz, M (17 June 1994). "Recovery of visual response of injured adult rat optic nerves treated with transglutaminase".
95:(lazy eye), an achievement which was previously considered impossible. He also invented methods of automatic measuring visual function in children and binocular treatment of amblyopia.
361:
Surinchak, John S.; Alago, Maria L.; Bellamy, Ronald F.; Stuck, Bruce E.; Belkin, Michael (1983). "Effects of low-level energy lasers on the healing of full-thickness skin defects".
109:
He was one of the first to prove that reducing visual acuity in the elderly, mostly due to improperly fitted or non-use of eyeglasses is associated with reduced cognitive functions.
986:
849:
Belokopytov, Mark; Shulman, Shiri; Dubinsky, Galina; Belkin, Michael; Rosner, Mordechai (2012). "Intravitreal Saline
Injection Ameliorates Laser-Induced Retinal Damage in Rats".
1117:
644:
Cohen, Yuval; Belkin, Michael; Yehezkel, Oren; Solomon, Arieh S.; Polat, Uri (2011). "Dependency between light intensity and refractive development under light–dark cycles".
607:
Schwartz, M.; Solomon, A.; Lavie, V.; Ben-Bassat, S.; Belkin, M.; Cohen, A. (1991). "Tumor necrosis factor facilitates regeneration of injured central nervous system axons".
87:
carried out the first-in Human
Clinical trials of the EAGLE. Their results found that their automated DSLT is a safe and effective method for reducing intraocular pressure.
1225:
Rapalino, O.; Lazarov-Spiegler, O.; Agranov, E.; Velan, G.J.; Yoles, E.; Fraidakis, M.; Soloman, A.; Gepstein, R.; Katz, A.; Belkin, M.; Hadani, M.; Schwartz, M. (1998).
72:
Belkin has been a voting member of SPIE, the
International Society for Optics and Photonics for 11 years, and serves on the organization's Conference Program Committee.
1315:
Tzameret, Adi; Sher, Ifat; Belkin, Michael; Treves, Avraham J.; Meir, Amilia; Nagler, Arnon; Levkovitch-Verbin, Hani; Rotenstreich, Ygal; Solomon, Arieh S. (2015).
1382:
1377:
1372:
690:
Traverso, C. E.; De Feo, F.; Messas-Kaplan, A.; Denis, P.; Levartovsky, S.; Sellem, E.; Badalà, F.; Zagorski, Z.; Bron, A.; Gandolfi, S.; Belkin, M. (2005).
570:
Schwartz, M; Belkin, M; Yoles, E; Solomon, A (1996). "Potential treatment modalities for glaucomatous neuropathy: neuroprotection and neuroregeneration".
806:
Nyska, Abraham; Glovinsky, Yoseff; Belkin, Michael; Epstein, Yoram (2003-06-12). "Biocompatibility of the Ex-PRESS miniature glaucoma drainage implant".
106:
Belkin identified a correlation between the development of myopia and years of schooling and intelligence in a substantial male population aged 17–19.
1317:"Epiretinal Transplantation of Human Bone Marrow Mesenchymal Stem Cells Rescues Retinal and Vision Function in a Rat Model of Retinal Degeneration"
116:
Belkin was part of a team researching the link between cigarette smoking and ocular disease, both through tobacco and exposure to passive smoke.
98:
Belkin is named as inventor or co-inventor on 16 patents registered in the United States and as inventor or applicant on 30 patents globally.
37:
He established and was the inaugural director of the Tel Aviv
University Eye Research Institute, located at the Sheba Medical Center.
1367:
1080:
1276:"Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: Phase I study results"
982:"External Automatic Glaucoma Laser (EAGLE) for the first-line glaucoma treatment: Commercial prototype development and validation"
696:
65:
He also publicized the threat of laser radiation to the eye and endeavoured to develop treatment for laser-induced eye injuries.
50:
179:
Solberg, Yoram; Rosner, Mordechai; Belkin, Michael (1998). "The
Association Between Cigarette Smoking and Ocular Diseases".
1001:
747:
303:
Solberg, Y.; Belkin, M. (1997). "The role of excitotoxicity in organophosphorous nerve agents central poisoning".
30:. His research brought about advances in glaucoma treatment such as the ExPress glaucoma implant, the Ioptimate CO
1275:
270:"Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardium"
917:
692:"Long term effects of a stainless steel glaucoma implant ExPRESS in combined surgery with phacoemulsification"
1132:
1280:
46:
1362:
84:
1028:
892:
512:
139:
91:
27:
1227:"Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats"
1256:
874:
831:
632:
595:
462:
424:
386:
785:
1338:
1297:
1248:
1207:
1152:
1099:
1056:
866:
823:
723:
661:
624:
587:
558:
528:
491:
454:
416:
378:
349:
320:
291:
255:
226:
196:
167:
1328:
1289:
1240:
1197:
1189:
1144:
1089:
1046:
1036:
858:
815:
713:
705:
653:
616:
579:
550:
520:
483:
446:
408:
370:
341:
312:
281:
247:
218:
188:
157:
147:
474:
Solberg, Yoram; Alcalay, Menachem; Belkin, Michael (1997). "Ocular injury by mustard gas".
1231:
332:
Rosner, M.; Belkin, M. (1 November 1987). "Intelligence, Education, and Myopia in Males".
1148:
345:
1032:
941:
516:
143:
1202:
1177:
981:
946:
718:
691:
1051:
1016:
487:
316:
251:
192:
162:
127:
1356:
819:
620:
583:
450:
412:
286:
269:
23:
1260:
835:
636:
599:
466:
390:
961:
428:
878:
862:
554:
1193:
657:
1333:
1316:
1293:
1094:
1075:
222:
1226:
1041:
709:
524:
152:
1342:
1301:
1211:
1103:
1060:
870:
827:
771:
727:
665:
562:
374:
259:
230:
171:
1252:
1156:
628:
591:
532:
495:
458:
420:
382:
353:
324:
295:
200:
34:
laser glaucoma surgery and a fast, non-contact glaucoma laser treatment.
1244:
1176:
Spierer, Oriel; Fischer, Naomi; Barak, Adiel; Belkin, Michael (2016).
1178:"Correlation Between Vision and Cognitive Function in the Elderly"
1074:
Yehezkel, Oren; Belkin, Michael; Wygnanski-Jaffe, Tamara (2020).
45:
Belkin completed a master's degree in natural sciences from the
1076:"Automated Diagnosis and Measurement of Strabismus in Children"
772:"Prof. Michael Belkin Emeritus in Eye Imstitute (Goldschleger)"
238:
Barkana, Yaniv; Belkin, Michael (2000). "Laser Eye Injuries".
126:
Polat, U.; Ma-Naim, T.; Belkin, M.; Sagi, D. (19 April 2004).
1017:"Improving vision in adult amblyopia by perceptual learning"
128:"Improving vision in adult amblyopia by perceptual learning"
1002:"Moorfields begins 'one second' glaucoma treatment trial"
748:"Dr. Michael Belkin, an eye doctor with uncommon vision"
1015:
Polat, U.; Ma-Naim, T.; Belkin, M.; Sagi, D. (2004).
685:
683:
918:"Glaucoma laser developer Belkin Laser raises $ 5m"
22:is an Israeli academic and researcher working in
90:GLAUrious began clinical trials in Italy at the
1021:Proceedings of the National Academy of Sciences
132:Proceedings of the National Academy of Sciences
1133:"Intelligence, Education, and Myopia in Males"
543:Ophthalmic Surgery, Lasers and Imaging Retina
274:Journal of the American College of Cardiology
113:vascular and ophthalmic diseases clinically.
8:
801:
799:
741:
739:
737:
1332:
1201:
1093:
1050:
1040:
717:
285:
161:
151:
76:Developments in ophthalmologic technology
26:, Professor Emeritus of Ophthalmology at
679:
49:, and a doctorate in medicine from the
746:Klein Leichman, Abigail (2013-08-29).
1383:Alumni of the University of Cambridge
1378:Hebrew University of Jerusalem alumni
1373:Academic staff of Tel Aviv University
1131:Rosner, M.; Belkin, M. (1987-11-01).
7:
1149:10.1001/archopht.1987.01060110054030
346:10.1001/archopht.1987.01060110054030
305:Trends in Pharmacological Sciences
14:
1081:American Journal of Ophthalmology
820:10.1097/00061198-200306000-00017
697:British Journal of Ophthalmology
584:10.1097/00061198-199612000-00012
16:Israeli ophthalmology professor
363:Lasers in Surgery and Medicine
211:Journal of Neurosurgery: Spine
51:Hebrew University of Jerusalem
1:
1182:Baltimore Journal of Medicine
916:Densford, Fink (2017-06-05).
897:Singapore National Eye Clinic
488:10.1016/s0039-6257(97)00021-0
317:10.1016/s0165-6147(97)89540-5
252:10.1016/s0039-6257(00)00112-0
193:10.1016/s0039-6257(98)00002-2
863:10.1097/IAE.0b013e318234942f
621:10.1016/0006-8993(91)91309-o
555:10.3928/15428877-20050101-07
451:10.1016/0006-8993(89)91240-7
413:10.1016/0165-5728(94)90209-7
287:10.1016/0735-1097(93)90790-8
1194:10.1097/MD.0000000000002423
1399:
786:"Michael Belkin biography"
658:10.1016/j.exer.2010.10.012
401:Journal of Neuroimmunology
1334:10.1016/j.scr.2015.08.007
1294:10.3171/spi.2005.3.3.0173
1137:Archives of Ophthalmology
1118:"EP2629841A2 BLIND SIGHT"
1095:10.1016/j.ajo.2019.12.018
962:"Profile: Michael Belkin"
646:Experimental Eye Research
334:Archives of Ophthalmology
223:10.3171/spi.2005.3.3.0173
1368:Israeli ophthalmologists
893:"Our Organisation Chart"
209:Phase I study results".
1281:Journal of Neurosurgery
1042:10.1073/pnas.0401200101
710:10.1136/bjo.2004.058032
525:10.1126/science.7911602
476:Survey of Ophthalmology
240:Survey of Ophthalmology
181:Survey of Ophthalmology
153:10.1073/pnas.0401200101
47:University of Cambridge
375:10.1002/lsm.1900020310
120:Selected publications
102:Research and findings
85:Sheba Medical Centre
1033:2004PNAS..101.6692P
808:Journal of Glaucoma
572:Journal of Glaucoma
517:1994Sci...264.1764E
511:(5166): 1764–1768.
144:2004PNAS..101.6692P
92:University of Genoa
28:Tel Aviv University
1245:10.1038/nm0798-814
942:"Belkin Laser Ltd"
1027:(17): 6692–6697.
340:(11): 1508–1511.
138:(17): 6692–6697.
1390:
1347:
1346:
1336:
1312:
1306:
1305:
1271:
1265:
1264:
1222:
1216:
1215:
1205:
1173:
1167:
1166:
1164:
1163:
1128:
1122:
1121:
1114:
1108:
1107:
1097:
1071:
1065:
1064:
1054:
1044:
1012:
1006:
1005:
998:
992:
991:
978:
972:
971:
969:
968:
958:
952:
951:
938:
932:
931:
929:
928:
913:
907:
906:
904:
903:
889:
883:
882:
846:
840:
839:
803:
794:
793:
782:
776:
775:
768:
762:
761:
759:
758:
743:
732:
731:
721:
687:
669:
640:
615:(1–2): 334–338.
603:
566:
536:
499:
470:
432:
394:
357:
328:
299:
289:
280:(7): 2001–2006.
263:
234:
204:
175:
165:
155:
1398:
1397:
1393:
1392:
1391:
1389:
1388:
1387:
1353:
1352:
1351:
1350:
1314:
1313:
1309:
1273:
1272:
1268:
1232:Nature Medicine
1224:
1223:
1219:
1175:
1174:
1170:
1161:
1159:
1143:(11): 1508–11.
1130:
1129:
1125:
1116:
1115:
1111:
1073:
1072:
1068:
1014:
1013:
1009:
1000:
999:
995:
980:
979:
975:
966:
964:
960:
959:
955:
940:
939:
935:
926:
924:
915:
914:
910:
901:
899:
891:
890:
886:
848:
847:
843:
805:
804:
797:
784:
783:
779:
770:
769:
765:
756:
754:
745:
744:
735:
689:
688:
681:
676:
643:
606:
569:
539:
502:
473:
435:
397:
360:
331:
302:
266:
237:
207:
178:
125:
122:
104:
78:
59:
43:
33:
17:
12:
11:
5:
1396:
1394:
1386:
1385:
1380:
1375:
1370:
1365:
1355:
1354:
1349:
1348:
1327:(2): 387–394.
1307:
1288:(3): 173–181.
1266:
1239:(7): 814–821.
1217:
1168:
1123:
1109:
1066:
1007:
993:
973:
953:
947:Bloomberg News
933:
908:
884:
857:(6): 1165–70.
841:
795:
777:
763:
733:
704:(4): 425–429.
678:
677:
675:
672:
671:
670:
641:
609:Brain Research
604:
567:
537:
500:
482:(6): 461–466.
471:
445:(2): 205–212.
439:Brain Research
433:
395:
369:(3): 267–274.
358:
329:
311:(6): 183–185.
300:
264:
246:(6): 459–478.
235:
217:(3): 173–181.
205:
187:(6): 535–547.
176:
121:
118:
103:
100:
77:
74:
58:
55:
42:
39:
31:
20:Michael Belkin
15:
13:
10:
9:
6:
4:
3:
2:
1395:
1384:
1381:
1379:
1376:
1374:
1371:
1369:
1366:
1364:
1363:Living people
1361:
1360:
1358:
1344:
1340:
1335:
1330:
1326:
1322:
1321:Stem Cell Res
1318:
1311:
1308:
1303:
1299:
1295:
1291:
1287:
1283:
1282:
1277:
1270:
1267:
1262:
1258:
1254:
1250:
1246:
1242:
1238:
1234:
1233:
1228:
1221:
1218:
1213:
1209:
1204:
1199:
1195:
1191:
1187:
1183:
1179:
1172:
1169:
1158:
1154:
1150:
1146:
1142:
1138:
1134:
1127:
1124:
1119:
1113:
1110:
1105:
1101:
1096:
1091:
1087:
1083:
1082:
1077:
1070:
1067:
1062:
1058:
1053:
1048:
1043:
1038:
1034:
1030:
1026:
1022:
1018:
1011:
1008:
1004:. 2019-12-17.
1003:
997:
994:
989:
988:
983:
977:
974:
963:
957:
954:
949:
948:
943:
937:
934:
923:
919:
912:
909:
898:
894:
888:
885:
880:
876:
872:
868:
864:
860:
856:
852:
845:
842:
837:
833:
829:
825:
821:
817:
814:(3): 275–80.
813:
809:
802:
800:
796:
792:. 2021-01-01.
791:
787:
781:
778:
773:
767:
764:
753:
749:
742:
740:
738:
734:
729:
725:
720:
715:
711:
707:
703:
699:
698:
693:
686:
684:
680:
673:
667:
663:
659:
655:
651:
647:
642:
638:
634:
630:
626:
622:
618:
614:
610:
605:
601:
597:
593:
589:
585:
581:
578:(6): 427–32.
577:
573:
568:
564:
560:
556:
552:
548:
544:
538:
534:
530:
526:
522:
518:
514:
510:
506:
501:
497:
493:
489:
485:
481:
477:
472:
468:
464:
460:
456:
452:
448:
444:
440:
434:
430:
426:
422:
418:
414:
410:
406:
402:
396:
392:
388:
384:
380:
376:
372:
368:
364:
359:
355:
351:
347:
343:
339:
335:
330:
326:
322:
318:
314:
310:
306:
301:
297:
293:
288:
283:
279:
275:
271:
265:
261:
257:
253:
249:
245:
241:
236:
232:
228:
224:
220:
216:
212:
206:
202:
198:
194:
190:
186:
182:
177:
173:
169:
164:
159:
154:
149:
145:
141:
137:
133:
129:
124:
123:
119:
117:
114:
110:
107:
101:
99:
96:
93:
88:
86:
82:
75:
73:
70:
66:
63:
56:
54:
52:
48:
40:
38:
35:
29:
25:
24:ophthalmology
21:
1324:
1320:
1310:
1285:
1279:
1269:
1236:
1230:
1220:
1185:
1181:
1171:
1160:. Retrieved
1140:
1136:
1126:
1112:
1085:
1079:
1069:
1024:
1020:
1010:
996:
985:
976:
965:. Retrieved
956:
945:
936:
925:. Retrieved
921:
911:
900:. Retrieved
896:
887:
854:
850:
844:
811:
807:
789:
780:
766:
755:. Retrieved
751:
701:
695:
652:(1): 40–46.
649:
645:
612:
608:
575:
571:
549:(1): 57–66.
546:
542:
508:
504:
479:
475:
442:
438:
404:
400:
366:
362:
337:
333:
308:
304:
277:
273:
243:
239:
214:
210:
184:
180:
135:
131:
115:
111:
108:
105:
97:
89:
83:
79:
71:
67:
64:
60:
44:
36:
19:
18:
1188:(3): 2423.
1088:: 226–234.
922:Mass Device
407:(1): 9–16.
1357:Categories
1162:2021-01-04
967:2021-01-04
927:2021-01-04
902:2021-01-04
757:2021-01-04
752:Israel 21c
674:References
41:Education
1343:26322852
1302:16235699
1261:22572079
1212:26817872
1104:31887281
1061:15096608
871:22290081
836:28002021
828:12782849
790:Wallmine
728:15774918
666:21055401
637:20900035
600:32199067
563:15688972
467:13302840
391:33939164
260:10906379
231:16235699
172:15096608
1253:9662373
1203:4998246
1157:3675282
1029:Bibcode
719:1772591
629:1860055
592:8946301
533:7911602
513:Bibcode
505:Science
496:9220568
459:2702463
429:3810035
421:8300861
383:6843266
354:3675282
325:9226993
296:7504006
201:9635902
140:Bibcode
1341:
1300:
1259:
1251:
1210:
1200:
1155:
1102:
1059:
1052:404107
1049:
987:Cordis
879:442241
877:
869:
851:Retina
834:
826:
726:
716:
664:
635:
627:
598:
590:
561:
531:
494:
465:
457:
427:
419:
389:
381:
352:
323:
294:
258:
229:
199:
170:
163:404107
160:
57:Career
1257:S2CID
875:S2CID
832:S2CID
633:S2CID
596:S2CID
463:S2CID
425:S2CID
387:S2CID
1339:PMID
1298:PMID
1249:PMID
1208:PMID
1153:PMID
1100:PMID
1057:PMID
867:PMID
824:PMID
724:PMID
662:PMID
625:PMID
588:PMID
559:PMID
529:PMID
492:PMID
455:PMID
417:PMID
379:PMID
350:PMID
321:PMID
292:PMID
256:PMID
227:PMID
197:PMID
168:PMID
1329:doi
1290:doi
1241:doi
1198:PMC
1190:doi
1145:doi
1141:105
1090:doi
1086:213
1047:PMC
1037:doi
1025:101
859:doi
816:doi
714:PMC
706:doi
654:doi
617:doi
613:545
580:doi
551:doi
521:doi
509:264
484:doi
447:doi
443:476
409:doi
371:doi
342:doi
338:105
313:doi
282:doi
248:doi
219:doi
189:doi
158:PMC
148:doi
136:101
1359::
1337:.
1325:15
1323:.
1319:.
1296:.
1284:.
1278:.
1255:.
1247:.
1235:.
1229:.
1206:.
1196:.
1186:95
1184:.
1180:.
1151:.
1139:.
1135:.
1098:.
1084:.
1078:.
1055:.
1045:.
1035:.
1023:.
1019:.
984:.
944:.
920:.
895:.
873:.
865:.
855:32
853:.
830:.
822:.
812:12
810:.
798:^
788:.
750:.
736:^
722:.
712:.
702:89
700:.
694:.
682:^
660:.
650:92
648:.
631:.
623:.
611:.
594:.
586:.
574:.
557:.
547:36
545:.
527:.
519:.
507:.
490:.
480:41
478:.
461:.
453:.
441:.
423:.
415:.
405:50
403:.
385:.
377:.
365:.
348:.
336:.
319:.
309:18
307:.
290:.
278:22
276:.
272:.
254:.
244:44
242:.
225:.
213:.
195:.
185:42
183:.
166:.
156:.
146:.
134:.
130:.
53:.
1345:.
1331::
1304:.
1292::
1286:3
1263:.
1243::
1237:4
1214:.
1192::
1165:.
1147::
1120:.
1106:.
1092::
1063:.
1039::
1031::
990:.
970:.
950:.
930:.
905:.
881:.
861::
838:.
818::
774:.
760:.
730:.
708::
668:.
656::
639:.
619::
602:.
582::
576:5
565:.
553::
535:.
523::
515::
498:.
486::
469:.
449::
431:.
411::
393:.
373::
367:2
356:.
344::
327:.
315::
298:.
284::
262:.
250::
233:.
221::
215:3
203:.
191::
174:.
150::
142::
32:2
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.